 |
| Pfizer CEO Ian Read |
Pfizer ($PFE) is doing some reorganization--the company said Monday that it would split its operations into three distinct units, two focused on "innovative" drugs and a third including so-called "value" business. After Pfizer was praised by investors when it sold off its nutrition unit to Nestlé and spun off its animal health business Zoetis, Pfizer CEO Ian Read said he'd consider breaking up the pharma giant into smaller units. Each new Pfizer unit will be headed by a group president. More